Dyskinesia, abnormal involuntary movements associated with long-term neuroleptic drug use, was evaluated with 344 institutionalized profoundly mentally retarded adults using the Dyskinesia Identification System Condensed User Scale. Results indicated performance deficits on activation tasks associated with intelligence quotients, neuroleptic dosage, gender, and ambulatory and visual impairments. (Author/DB)